EP1248855A4 - Sequences caracteristiques du cancer de la vessie - Google Patents

Sequences caracteristiques du cancer de la vessie

Info

Publication number
EP1248855A4
EP1248855A4 EP00977267A EP00977267A EP1248855A4 EP 1248855 A4 EP1248855 A4 EP 1248855A4 EP 00977267 A EP00977267 A EP 00977267A EP 00977267 A EP00977267 A EP 00977267A EP 1248855 A4 EP1248855 A4 EP 1248855A4
Authority
EP
European Patent Office
Prior art keywords
bladder cancer
sequences characteristic
sequences
characteristic
bladder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00977267A
Other languages
German (de)
English (en)
Other versions
EP1248855A2 (fr
Inventor
Elena Feinstein
Orna Mor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quark Pharmaceuticals Inc
Original Assignee
Quark Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quark Biotech Inc filed Critical Quark Biotech Inc
Publication of EP1248855A2 publication Critical patent/EP1248855A2/fr
Publication of EP1248855A4 publication Critical patent/EP1248855A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP00977267A 1999-09-27 2000-09-27 Sequences caracteristiques du cancer de la vessie Withdrawn EP1248855A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15615399P 1999-09-27 1999-09-27
US156153P 1999-09-27
PCT/US2000/041005 WO2001022864A2 (fr) 1999-09-27 2000-09-27 Sequences caracteristiques du cancer de la vessie

Publications (2)

Publication Number Publication Date
EP1248855A2 EP1248855A2 (fr) 2002-10-16
EP1248855A4 true EP1248855A4 (fr) 2004-12-22

Family

ID=22558336

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00977267A Withdrawn EP1248855A4 (fr) 1999-09-27 2000-09-27 Sequences caracteristiques du cancer de la vessie

Country Status (5)

Country Link
EP (1) EP1248855A4 (fr)
AU (1) AU1492601A (fr)
CA (1) CA2385893A1 (fr)
IL (1) IL148798A0 (fr)
WO (1) WO2001022864A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6998232B1 (en) 1999-09-27 2006-02-14 Quark Biotech, Inc. Methods of diagnosing bladder cancer
AU2002338431A1 (en) * 2001-04-04 2002-11-05 Quark Biotech, Inc. Sequence characteristics of bladder cancer
NZ595684A (en) 2004-07-23 2013-06-28 Pacific Edge Biotechnology Ltd Urine markers for detection of bladder cancer
JP5109131B2 (ja) 2005-02-10 2012-12-26 オンコセラピー・サイエンス株式会社 膀胱癌を診断する方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856136A (en) * 1996-07-03 1999-01-05 Incyte Pharmaceuticals, Inc. Human stem cell antigens
DE19818619A1 (de) * 1998-04-21 1999-10-28 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Blase-Tumor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856136A (en) * 1996-07-03 1999-01-05 Incyte Pharmaceuticals, Inc. Human stem cell antigens
DE19818619A1 (de) * 1998-04-21 1999-10-28 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Blase-Tumor

Also Published As

Publication number Publication date
AU1492601A (en) 2001-04-30
WO2001022864A2 (fr) 2001-04-05
WO2001022864A3 (fr) 2001-11-01
WO2001022864A9 (fr) 2002-12-12
IL148798A0 (en) 2002-09-12
EP1248855A2 (fr) 2002-10-16
CA2385893A1 (fr) 2001-04-05

Similar Documents

Publication Publication Date Title
AU7680300A (en) Human dna sequences
AU2002319338A1 (en) Cancer specific oligosaccharide sequences and use thereof
EP1320376A4 (fr) Traitement du cancer de la prostate
SI1176964T1 (sl) Uporaba et743 za zdravljenje raka
AU7129700A (en) Ovarian tumor sequences and methods of use therefor
HK1044111A1 (en) Improved cancer treatment with temozolomide
IL148798A0 (en) Sequences characteristic of bladder cancer
IL149093A0 (en) Short segments of dap-kinase
EP1218407A4 (fr) Utilisation de la kappa-conotoxine pviia
IL149281A0 (en) Treatment of cancer
AU5552400A (en) Treatment of cancer
GB0026015D0 (en) Cancer treatment
GB0011459D0 (en) Sequences
AU2002338431A1 (en) Sequence characteristics of bladder cancer
PL350963A1 (en) Use of arylalkanoylpyridazines
GB0210912D0 (en) Sequences encoding human neoplastic marker
EP1225222A4 (fr) Nouveau gene suppresseur des tumeurs
AU2001289127A1 (en) Tumor treatment
AU1199201A (en) Breast tumor sequences and methods of use therefor
HUP0202614A3 (en) Use of thienopyrimidines
GB9911183D0 (en) Treatment of cancers
GB9927005D0 (en) Treatment of cancers
GB9918534D0 (en) Treatment of cancers
GB9911346D0 (en) Treatment of cancers
GB9927106D0 (en) Cancer treatment

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020426

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20041104

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050121